We did not detect significant therapeutic effects of AAV5-Hsp70 on R6/2 mice unlike AAV5-Hsp40, possibly due to the very low infection rate of our AAV5-Hsp70 (data not shown), or differences in the effectiveness of Hsp40 and Hsp70 against mutant htt. This evidence concerns the gene HTT and infection.